Within the broader spectrum of BC, triple-negative breast cancer (TNBC) represents an aggressive and distinct subtype, characterized by the absence of ER, PR, and HER2 expression, making it more challenging to treat and often associated with poorer prognosis. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.